Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Borsi

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
How much is too much? Folinic acid rescue dose in children with acute lymphoblastic leukaemiaJ D Borsi, F Wesenberg, T Stokland, et al.
Haematology and Blood Transfusion|January 1, 1990
Pharmacokinetics of folinic acid in children with acute lymphoblastic leukemiaJ D Borsi, E Sagen, I Romslo, et al.
Medical and Pediatric Oncology|January 1, 1990
Comparative study on the pharmacokinetics of 7-hydroxy-methotrexate after administration of methotrexate in the dose range of 0.5-33.6 g/m2 to children with acute lymphoblastic leukemiaJ D Borsi, E Sagen, I Romslo, et al.
Pediatric Hematology and Oncology|January 1, 1990
Pharmacokinetics and metabolism of methotrexate: an example for the use of clinical pharmacology in pediatric oncologyJ D Borsi, E Sagen, I Romslo, et al.
Pediatric Hematology and Oncology|January 1, 1990
Rescue after intermediate and high-dose methotrexate: background, rationale, and current practiceJ D Borsi, E Sagen, I Romslo, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
7-Hydroxymethotrexate concentrations in serum and cerebrospinal fluid of children with acute lymphoblastic leukemiaJ D Borsi, E Sagen, I Romslo, et al.
Medical and Pediatric Oncology|May 1, 1996
Diffuse plasmacytosis in a child with brainstem glioma following multiagent chemotherapy and intensive growth factor supportC Csáki, T Ferencz, G Sipos, et al.
Anti-Cancer Drugs|December 5, 1998
Effect of etoposide on the pharmacokinetics of methotrexate in vivoK Paál, J Horváth, C Csáki, et al.
Transplantation Proceedings|November 22, 2005
Results of a multilateral approach to donation-transplantation process in Hungary in the past 2 yearsJ D Borsi, P Borka, E Tornai, et al.
Pediatric Hematology and Oncology|March 1, 1994
Evaluation of serious adverse events in patients treated with protocols including methotrexate infusionsH Seidel, P J Moe, R Nygaard, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
How much is too much? Folinic acid rescue dose in children with acute lymphoblastic leukaemiaJ D Borsi, F Wesenberg, T Stokland, et al.
Haematology and Blood Transfusion|January 1, 1990
Pharmacokinetics of folinic acid in children with acute lymphoblastic leukemiaJ D Borsi, E Sagen, I Romslo, et al.
Medical and Pediatric Oncology|January 1, 1990
Comparative study on the pharmacokinetics of 7-hydroxy-methotrexate after administration of methotrexate in the dose range of 0.5-33.6 g/m2 to children with acute lymphoblastic leukemiaJ D Borsi, E Sagen, I Romslo, et al.
Pediatric Hematology and Oncology|January 1, 1990
Pharmacokinetics and metabolism of methotrexate: an example for the use of clinical pharmacology in pediatric oncologyJ D Borsi, E Sagen, I Romslo, et al.
Pediatric Hematology and Oncology|January 1, 1990
Rescue after intermediate and high-dose methotrexate: background, rationale, and current practiceJ D Borsi, E Sagen, I Romslo, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
7-Hydroxymethotrexate concentrations in serum and cerebrospinal fluid of children with acute lymphoblastic leukemiaJ D Borsi, E Sagen, I Romslo, et al.
Medical and Pediatric Oncology|May 1, 1996
Diffuse plasmacytosis in a child with brainstem glioma following multiagent chemotherapy and intensive growth factor supportC Csáki, T Ferencz, G Sipos, et al.
Anti-Cancer Drugs|December 5, 1998
Effect of etoposide on the pharmacokinetics of methotrexate in vivoK Paál, J Horváth, C Csáki, et al.
Transplantation Proceedings|November 22, 2005
Results of a multilateral approach to donation-transplantation process in Hungary in the past 2 yearsJ D Borsi, P Borka, E Tornai, et al.
Pediatric Hematology and Oncology|March 1, 1994
Evaluation of serious adverse events in patients treated with protocols including methotrexate infusionsH Seidel, P J Moe, R Nygaard, et al.
Pageof 3